Skip to main content
Log in

Intrapatient variation in tobramycin kinetics in low birth weight infants during first postnatal week

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Nineteen newborn infants receiving tobramycin, 2.5 mg/kg every 12 h were studied on two occasions at steady-state during the first week of postnatal age. The two studies were separated by two to four days. Total body clearance of tobramycin averaged 1.15 and 1.14 ml/min/kg (p>0.05), apparent volume of distribution averaged 0.82 and 0.68 l/kg (p>0.05), and elimination half-life averaged 8.6 and 7.1 h (p>0.05), during the first and second study, respectively. When the data were further analyzed based on the birth weight, tobramycin kinetics changed during the second study compared to the first study in very low birth weight infants. In eight infants ⩽1.5 kg birth weight, although total clearance of tobramycin was similar, the average apparent volume of distribution decreased from 1.04 l/kg during the first study to 0.73 l/kg during the second study (p<0.05) and elimination half-life from 11.1 h during the first study to 8.7 h during the second study (p<0.05). These data indicate that these infants may require a change in dosing interval with continued tobramycin therapy during the first week of postnatal age. Intrapatient variation in tobramycin kinetics should be considered, in addition to the interpatient variation reported previously, when monitoring the serum concentration to individualize tobramycin therapy in newborn infants ⩽1.5 kg birth weight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arant BS (1982) Fluid therapy in the neonate — concepts in transition. J Pediatr 101: 387–389

    Google Scholar 

  2. Williams V, Shirkey HC (1976) Pediatric clinical pharmacology and therapeutics. In: Avery GS (ed) Drug treatment. ADIS Press, Publishing Sciences Group, Acton, MA, USA, pp 71–122

    Google Scholar 

  3. Bell EF, Oh W (1978) Fluid and electrolyte balance in low birth weight infants. Clin Perinatol 6: 139–146

    Google Scholar 

  4. Dahlgren JG, Anderson ET, Hewitt WL (1975) Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother 8: 58–62

    Google Scholar 

  5. Lorenz JM, Kleinman LI, Kotagal VR, Reller MD (1983) Water balance in very low-birth-weight infants: relationship to water and sodium intake and effect on outcome. J Pediatr 101: 423–432

    Google Scholar 

  6. Nahata MC, Powell DA, Gregoire RP, McClead RE, Menke JA, Bickers RG, Glazer JP (1983) Tobramycin kinetics in newborn infants. J Pediatr 103: 136–139

    Google Scholar 

  7. Physician's desk reference (1983) 37th edn. Medical Economics, Oradell, NJ, USA, pp 900–902

Download references

Author information

Authors and Affiliations

Authors

Additional information

supported by Lilly Research Laboratories, Indianapolis, USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nahata, M.C., Powell, D.A., Durrell, D.E. et al. Intrapatient variation in tobramycin kinetics in low birth weight infants during first postnatal week. Eur J Clin Pharmacol 26, 647–649 (1984). https://doi.org/10.1007/BF00543504

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543504

Key words

Navigation